http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-79843-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba782d3b1fd168eab19dd7b0875942aa
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-12
filingDate 2003-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d039248b4b745823f5bbf7eae7960d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1148e61a99ea21589cb65f019e164f37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1ddbaf6d51740b3cff314f5a47f786d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cb041dd0fd0a8566b8e03788e6233a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d5072952ec08c5aed598119552ee776
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce84f51c8c413d3073c5297b04576e69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bf5b9405726850f197334cc49b6bafb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a2df00b1557155d6bff6e0d9abb9ac7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1f5b2980a8804bca29d54093be5fa20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10244d8306b430fbcc11122d49dc6e64
publicationDate 2007-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UA-79843-C2
titleOfInvention 4-substituted benzimidazoles and their application as gastric secretion inhibitors
abstract The invention relates to 6-substituted benzimidazoles of formula 1, in which X is O (oxygen) or NH and Y has either I the meaning -CH2-Ar wherein Ar is a mono- or bicyclic aromatic residue, or Y denotes the group gp, formula (gp) wherein Z has the meaning -CHR8- or -CHR8-CHR9-. The compounds have gastric secretion inhibiting and excellent gastric and intestinal protective action properties.
priorityDate 2002-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977

Total number of triples: 27.